Dr. Smaill is a professor of pathology and molecular medicine, an acting associate vice-president of the Faculty of Health Sciences, and a co-director at the Special Immunology Services/HIV Clinic at McMaster University.
She earned her medical degree at Otago University in New Zealand and followed with training in general medicine at the Wellington Hospital. She then made the move to McMaster University in Hamilton where she trained in medical microbiology, internal medicine, and infectious diseases before completing a master’s degree in design, measurement & evaluation.
Dr. Smaill’s research interests include evaluating the efficacy and side effects of different antiretroviral regimens as well as gender differences in the management of HIV. Beyond HIV, she is actively involved in clinical trials focused on the development of vaccines for tuberculosis and the management of infections in pregnancy.
With the CTN, she is most involved in the CTN’s Clinical Care and Management Core. She is a co-investigator for CTN 273: Brain Health Now!, CTN 254: Inflammation as a predictor of HIV disease progression, and CTN 240: VALIDATE trial. She is also a co-investigator for CTN 247: Canadian cohort of HIV+ slow progressors, which is in the Vaccines and Immunotherapies core.